Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Nan Zhu PhD

Nan Zhu PhD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Cell Biology, Neurobiology and Anatomy
Program: Administration

Member of the Cancer Center


Publications

  • DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia. (Chen CW, Koche RP, Sinha AU, Deshpande AJ, Zhu N, Eng R, Doench JG, Xu H, Chu SH, Qi J, Wang X, Delaney C, Bernt KM, Root DE, Hahn WC, Bradner JE, Armstrong SA) Nat Med 2015 Apr;21(4):335-43 PMID: 25822366 PMCID: PMC4390532 03/31/2015
  • AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes. (Deshpande AJ, Deshpande A, Sinha AU, Chen L, Chang J, Cihan A, Fazio M, Chen CW, Zhu N, Koche R, Dzhekieva L, Ibáñez G, Dias S, Banka D, Krivtsov A, Luo M, Roeder RG, Bradner JE, Bernt KM, Armstrong SA) Cancer Cell 2014 Dec 08;26(6):896-908 PMID: 25464900 PMCID: PMC4291116 12/04/2014
  • CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. (Huang CH, Lujambio A, Zuber J, Tschaharganeh DF, Doran MG, Evans MJ, Kitzing T, Zhu N, de Stanchina E, Sawyers CL, Armstrong SA, Lewis JS, Sherr CJ, Lowe SW) Genes Dev 2014 Aug 15;28(16):1800-14 PMID: 25128497 PMCID: PMC4197965 08/17/2014
  • Notch pathway activation targets AML-initiating cell homeostasis and differentiation. (Lobry C, Ntziachristos P, Ndiaye-Lobry D, Oh P, Cimmino L, Zhu N, Araldi E, Hu W, Freund J, Abdel-Wahab O, Ibrahim S, Skokos D, Armstrong SA, Levine RL, Park CY, Aifantis I) J Exp Med 2013 Feb 11;210(2):301-19 PMID: 23359070 PMCID: PMC3570103 01/30/2013
  • STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2. (Tam WF, Hähnel PS, Schüler A, Lee BH, Okabe R, Zhu N, Pante SV, Raffel G, Mercher T, Wernig G, Bockamp E, Sasca D, Kreft A, Robinson GW, Hennighausen L, Gilliland DG, Kindler T) Cancer Res 2013 Jan 01;73(1):373-84 PMID: 23149921 PMCID: PMC3916953 11/15/2012
  • Polycomb repressive complex 2 is required for MLL-AF9 leukemia. (Neff T, Sinha AU, Kluk MJ, Zhu N, Khattab MH, Stein L, Xie H, Orkin SH, Armstrong SA) Proc Natl Acad Sci U S A 2012 Mar 27;109(13):5028-33 PMID: 22396593 PMCID: PMC3324004 03/08/2012
  • Chromatin-modifying enzymes as modulators of reprogramming. (Onder TT, Kara N, Cherry A, Sinha AU, Zhu N, Bernt KM, Cahan P, Marcarci BO, Unternaehrer J, Gupta PB, Lander ES, Armstrong SA, Daley GQ) Nature 2012 Mar 04;483(7391):598-602 PMID: 22388813 PMCID: PMC3501145 03/06/2012
  • Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains. (Trowbridge JJ, Sinha AU, Zhu N, Li M, Armstrong SA, Orkin SH) Genes Dev 2012 Feb 15;26(4):344-9 PMID: 22345515 PMCID: PMC3289882 02/22/2012
  • A functional role for the histone demethylase UTX in normal and malignant hematopoietic cells. (Liu J, Mercher T, Scholl C, Brumme K, Gilliland DG, Zhu N) Exp Hematol 2012 Jun;40(6):487-98.e3 PMID: 22306297 02/07/2012
  • MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. (Bernt KM, Zhu N, Sinha AU, Vempati S, Faber J, Krivtsov AV, Feng Z, Punt N, Daigle A, Bullinger L, Pollock RM, Richon VM, Kung AL, Armstrong SA) Cancer Cell 2011 Jul 12;20(1):66-78 PMID: 21741597 PMCID: PMC3329803 07/12/2011
  • Transcriptional regulation by HMGN proteins. (Zhu N, Hansen U) Biochim Biophys Acta 2010 Jan-Feb;1799(1-2):74-9 PMID: 20123070 PMCID: PMC2818479 02/04/2010
  • HMGN1 modulates estrogen-mediated transcriptional activation through interactions with specific DNA-binding transcription factors. (Zhu N, Hansen U) Mol Cell Biol 2007 Dec;27(24):8859-73 PMID: 17938209 PMCID: PMC2169410 10/17/2007
  • Last update: 07/21/2015
    jenkins-FCD Prod-130 96200611f8481f0aa4f84230b11dd74d063847a3